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SUMMARY
Beyond sample curation and basic pathologic characterization, the digitized H&E-stained images 
of TCGA samples remain underutilized. To highlight this resource, we present mappings of tumor-
infiltrating lymphocytes (TILs) based on H&E images from 13 TCGA tumor types. These TIL 
maps are derived through computational staining using a convolutional neural network trained to 
classify patches of images. Affinity propagation revealed local spatial structure in TIL patterns and 
correlation with overall survival. TIL map structural patterns were grouped using standard 
histopathological parameters. These patterns are enriched in particular T cell subpopulations 
derived from molecular measures. TIL densities and spatial structure were differentially enriched 
among tumor types, immune subtypes, and tumor molecular subtypes, implying that spatial 
infiltrate state could reflect particular tumor cell aberration states. Obtaining spatial lymphocytic 
patterns linked to the rich genomic characterization of TCGA samples demonstrates one use for 
the TCGA image archives with insights into the tumor-immune microenvironment.
In Brief
Tumor-infiltrating lymphocytes (TILs) were identified from standard pathology cancer images by 
a deep-learning-derived “computational stain” developed by Saltz et al. They processed 5,202 
digital images from 13 cancer types. Resulting TIL maps were correlated with TCGA molecular 
data, relating TIL content to survival, tumor subtypes, and immune profiles.
Saltz et al. Page 2
Cell Rep. Author manuscript; available in PMC 2018 May 10.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
INTRODUCTION
Although studies in humans have shown that chronic inflammation can promote 
tumorigenesis (Trinchieri, 2012), the host immune system is equally capable of controlling 
tumor growth through the activation of adaptive and innate immune mechanisms (Galon et 
al., 2013). Such intratumoral processes are often referred to collectively as immunoediting, 
where this selective pressure can result in the emergence of tumor cells that escape immune 
surveillance and, ultimately, to tumor progression. At the same time, many observations 
suggest that high densities of tumor-infiltrating lymphocytes (TILs) correlate with favorable 
clinical outcomes (Mlecnik et al., 2011a) such as longer disease-free survival or improved 
overall survival (OS) in multiple cancer types (Angell and Galon, 2013). Recent studies 
further suggest that the importance of spatial context and the nature of cellular heterogeneity 
of the tumor microenvironment, in terms of the immune infiltrate involving the tumor center 
and/or invasive margin, can also correlate with cancer prognosis (Fridman et al., 2012). 
Prognostic factors, most notably the Immunoscore, that quantify such spatial TIL densities 
in different tumor regions have high prognostic value that can significantly supplement and 
sometimes even supersede the standard TNM classification and staging in certain 
settings(Galon et al., 2006; Broussard and Disis, 2011; Mlecnik et al., 2011b). Given this 
and the central role of immunotherapy treatments in contemporary cancer care, these 
assessments of tumor-associated lymphocytes are increasingly important both in the clinical 
assessment of pathology slides, as well as in translational research into the role of these 
lymphocytic populations.
Tissue diagnostic studies are carried out and interpreted by pathologists for virtually all 
cancer patients, and the overwhelming majority of these are stained with hematoxylin and 
eosin (H&E). The TCGA Pan Cancer Atlas dataset includes representative H&E diagnostic 
whole-slide images (WSIs) that enable spatial quantification and analysis of TILs and 
association with the wealth of molecular characterization conducted through the TCGA. 
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Previously, this rich trove of imaging data has primarily been used solely to qualify samples 
for TCGA analysis and gleaning of some limited histopathologic parameters by expert 
pathologists. Using digital pathology and digitized whole-slide diagnostic tissue images, 
machine learning and deep learning approaches can create a “Computational Stain.” This 
allows identification and quantification of image features to formulate higher-order 
relationships that go beyond simple densities (e.g., of TILs) to explore quantitative 
assessments of lymphocyte clustering patterns, as well as characterization of the 
interrelationships between TILs and tumor regions. We apply this to the TCGA samples in a 
broad multi-cancer fashion. Only a few TCGA tumor types have been explored for TIL 
content based on feature extraction from histologic H&E images and in a more limited 
fashion (Rutledge et al., 2013; Cancer Genome Atlas Research Network, 2017).
Over the past 12 years, The Cancer Genome Atlas (TCGA) has profoundly illuminated the 
genomic landscape of human malignancy. More recently, it has been recognized that 
genomic data derived from bulk tumor samples, which include the tumor stromal, vascular, 
and immune compartments, as well as tumor cells, can provide detailed information about 
the tumor immune microenvironment. Molecular subtypes of ovarian, melanoma, and 
pancreatic cancer have been defined based on measures of immune infiltration (Cancer 
Genome Atlas Research Network, 2011; Cancer Genome Atlas Network, 2015; Bailey et al., 
2016), and a number of other tumors show variation in immune gene expression by 
molecular subtype (Iglesia et al., 2014, 2016; Kardos et al., 2016). Recent publications 
(Charoentong et al., 2017; Li et al., 2016; Rooney et al., 2015) have presented 
comprehensive analyses of TCGA data on the basis of immune content response. A recent 
study (Thorsson et al., 2018) reports on a series of immunogenomic characterizations that 
include assessments such as total lymphocytic infiltrate, immune cell type fractions, immune 
gene expression signatures, HLA type and expression, neoantigen prediction, T cell and B 
cell repertoire, and viral RNA expression. From these base-level results, integrative analyses 
were performed to derive six immune subtypes, spanning tumor types and subtypes. The 
comprehensive pairing of clinical, sample, molecular tumor, and immune characterizations 
with H&E WSIs in the TCGA is a unique resource (Cooper et al., 2017) and offers the 
possibility of identifying relationships between computational staining of whole-slide 
images and other measures of immune response that may in turn inform research into 
immuno-oncological therapy. In this work, we characterize spatial patterns of TILs and 
present relationships between TIL patterns and immune subtypes, tumor types, immune cell 
fractions, and patient survival, illustrating the potential of this kind of analysis and the kinds 
of questions that can be explored. For example, through integration of spatial patterns with 
molecular TIL characterization, we found evidence for these patterns being enriched in 
particular T cell populations.
This study represents an important milestone in the use of digital-pathology-based 
quantification as we are able to present results relating spatial and molecular tumor immune 
characterizations for roughly 5,000 patients with 13 cancer types. TILs and spatial 
characterizations of TILs have shown significant value in diagnostic and prognostic settings, 
and the ability to quantify TILs from diagnostic tissue has proven to be demanding, 
expensive, challenging to scale, and beleaguered by subjectivity. Human review of 
diagnostic tissue is highly effective for traditional diagnosis but is qualitative and thus is 
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prone to both inter- and intra- observer variability, particularly when attempting to quantify 
or reproducibly characterize feature-rich phenomena such as tumor-associated lymphocytic 
infiltrates. The spatial characterizations we present are high resolution, with TIL infiltration 
assessed in whole-slide images at a 50-micron resolution, and all TIL maps are available to 
the scientific community for further exploration. The recent FDA approval (FDA News 
Release, 2017) of whole-slide imaging for primary diagnostic use is leading to more 
widespread adoption of digital whole-slide imaging. It is widely expected that, within 5–10 
years, the great majority of new pathology slides will be digitized, thus enabling the 
development and clinical adoption of various digital-pathology-based diagnostic and 
prognostic biomarkers that will likely provide decision support for traditional pathologic 
interpretation in the clinical setting.
RESULTS
Generating Maps of Tumor-Infiltrating Lymphocytes using Convolutional Neural Networks
In order to accurately generate maps of tumor-infiltrating lymphocytes (TIL Maps) from 
digitized H&E stained tissue specimens, we developed a comprehensive methodology and 
accompanying interactive tools. This methodology is termed Computational Staining and 
employs deep learning methods to analyze images and tools to incorporate expert feedback 
into the deep learning models. Such iterative feedback results in the improvement of the 
overall accuracy of TIL Maps. Key highlights and the validation strategy for Computational 
Staining are presented here, with further details provided in the Method Details.
Computational Staining uses convolutional neural networks (CNNs) to identify lymphocyte-
infiltrated regions in digitized H&E stained tissue specimens. The CNN is a supervised deep 
learning method that has been successfully applied in a large number of image analysis 
problems (Cireşan et al., 2013; Huang et al., 2016; Xie et al., 2015a, 2015b; Wang et al., 
2016; Sirinukunwattana et al., 2016; Bayramoglu and Heikkila, 2016; Su et al., 2015; Hou et 
al., 2016a; Murthy et al., 2017;Chen et al., 2017; Xu and Huang, 2016). A CNN first uses a 
set of training data to learn a classification (or predictive) model in the training phase. The 
resulting trained model is then used to classify new data elements in a prediction phase. 
Deep-learning-based automatic analysis methods generally require large annotated datasets. 
Many state-of-the-art methods employ semi-supervised training strategies to boost trained 
model performance using unlabeled data (Ranzato et al., 2006; Masci et al., 2011; 
Bayramoglu and Heikkila, 2016; Xu and Huang, 2016; Su et al., 2015). They (1) pre-train an 
autoencoder for unsupervised representation learning; (2) construct a CNN from the 
pretrained autoencoder; and (3) fine-tune the constructed CNN for supervised classification. 
One can train the unsupervised autoencoder on image patches with the object to be classified 
(e.g., nucleus) in the center of each patch (Hou et al., 2016a; Murthy et al., 2017) in order to 
capture the visual variance of the object more accurately. This method, however, requires a 
separate object detection step. Instead of tuning the detection and classification modules 
separately, recent studies (Graves and Jaitly, 2014; Ren et al., 2015; Redmon et al., 2016; 
Kokkinos 2017) have developed CNNs to perform these tasks in a unified but fully 
supervised pipeline.
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Our methodology uses two CNNs: a lymphocyte infiltration classification CNN (lymphocyte 
CNN) and a necrosis segmentation CNN (necrosis CNN). The lymphocyte CNN categorizes 
tiny patches of an input image into those with lymphocyte infiltration and those without. It is 
a semi-supervised CNN, initialized by an unsupervised convolutional autoencoder (CAE). 
The necrosis CNN segments the regions of necrosis and is designed to eliminate false 
positives from necrotic regions where nuclei may have characteristics similar to those in 
lymphocyte-infiltrated regions. Details about the two CNNs are shown in Figure S1A and 
described in the Method Details.
Figure 1 illustrates both the training and model development phase of our methodology (top 
half of the figure) and the use of the trained model to generate TIL Maps (bottom half of the 
figure). The CNN training and model development phase starts with expert pathologists 
reviewing a set of images and marking regions of lymphocytes and necrosis. The 
lymphocyte and necrosis regions are then subdivided into tiny patches to create the initial 
training dataset. Training with patches rather than with individual regions and cells is done 
for computational efficiency. The lymphocyte CNN is trained with 50 × 50 μm2 patches 
(equivalent to 100 × 100 square pixel patches in tissue images acquired at 20× magnification 
level) from WSIs. The necrosis CNN is trained with larger patches of size 500 × 500 μm2, as 
more contextual information results in superior prediction of patches being necrotic. The 
initial training step is followed by an iterative cycle of review and refinement steps to 
improve the prediction accuracy of the lymphocyte CNN. This prediction step generates a 
probability value of lymphocyte infiltration for each patch in the images. The patch-level 
predictions for an image are combined and represented to pathologists as a heatmap for 
review and visual editing using our TIL-Map editor tool. The pathologists refine the CNN 
predictions for an image by first adjusting the probability value threshold (which globally 
updates the labels of the patches in the image; if the probability value of a patch exceeds the 
adjusted threshold, the patch is labeled a TIL patch) and then manually editing the heatmap 
to correct prediction errors for individual or groups of patches. At the end of the editing step, 
the updated heatmaps are processed to augment the training dataset. The lymphocyte CNN 
is re-trained with the updated training dataset. This iterative process continues until adequate 
prediction accuracy is achieved, as determined by the pathologist feedback. The necrosis 
CNN was retrained only once in this study, because it achieved sufficient prediction 
accuracy. The training and re-training steps of both CNNs involve cross-validation to assess 
prediction performance and avoid overfitting (Hou et al., 2017). See the Method Details for 
an in-depth description of this process.
The trained models are used on test datasets (bottom half of Figure 1). In this work, we 
applied our method to 5,455 diagnostic H&E WSIs from 13 TCGA tumor types in which 
lymphocytes are known to be present. See Additional Resources for listing and acronyms. 
We included uveal melanoma (UVM) as one of the 13 cancer types essentially as a type of 
negative control (Figure S3A), since it has the fewest immune cells among TCGA tumors 
(Thorsson et al., 2018). Tumor types were selected to represent a range of known positive 
involvement of lymphocytes and immunogenicity from literature and from molecular 
estimates of lymphocyte content. Each image was partitioned into patches of 50 × 50 μm2 
and each patch was classified by the CNNs. TIL maps were successfully generated (see 
Figure S1C and Table S2) for 5,202 TCGA tumor images from 4,759 individual participants 
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in the 13 tumor types. 253 images (4.6%) did not yield TIL maps because of low image 
quality or low prediction accuracy or because the images were duplicates (see Figure S1C).
We assessed the performance of our approach in two complementary, yet orthogonal ways. 
The first assessment method, described in Zhao et al. (2017), compares performance 
prediction of our method with that of a popular and widely used CNN—called VGG16 
(Simonyan and Zisserman, 2014)—using a set of WSIs from TCGA lung adenocarcinoma 
(LUAD) cases. The training set of the lymphocyte CNN consisted of 20,876 patches. Each 
patch usually contains 0 to 30 nuclei and was annotated by a pathologist as lymphocyte 
infiltrated or not lymphocyte infiltrated. The training set of the necrosis segmentation CNN 
consisted of 1,800 patches. Each patch was annotated with a necrosis region mask 
segmented by a pathologist. We sampled 2,480 patches to create the test dataset. The ROC 
curve shows that our approach slightly outperforms VGG16 by 3.1% with respect to the area 
under ROC curve (AUROC) metric (Figure 2A). We also performed direct comparison of 
TIL patch assignments by the Computational Staining pipeline with those by experienced 
pathologists by scoring 8 × 8 “super-patches” for TIL content. Three pathologists assessed 
400 super-patches as having low, medium, or high TIL content, while machine-derived 
scores were assigned for the patch by counting TIL-positive patches (thus ranging from 0 to 
64). Consistency was high among each of the pathologists (> 80%), as assessed by rescoring 
of 100 super-patches. As seen in Figure 2B, the median machine-derived score is quite 
distinct between the three ordinal bins. This is evidenced in strong correlation as assessed by 
the polyserial coefficient (Drasgow, 2014), designed for comparing ordinal with continuous 
values (0.36 with 95% CI [0.27,0.45], p value = 5.2 × 10−15, R package polycor).
Assessment and Correlates of TIL Spatial Fraction
Spatial Fraction of TILs—The spatial fraction of TILs was estimated as the fraction of 
TIL-positive patches among the total number of patches identified on the tissue sample. A 
wide range in spatial infiltrate is seen among the TCGA tumor types (Figure 3A and Table 
S1), with high infiltrates in gastric cancer (STAD) with a mean of 14.6%, rectal cancer 
(READ) at 13.0%, squamous cell carcinoma in the lung (LUSC) at 11.6%, while uveal 
melanoma (UVM) has only 1% estimated TIL fraction, consistent with its inclusion as 
negative control (Figure S3A). Wide differences are also seen grouping tumors by the nature 
of the immune response, according to a recent immune characterization of all TCGA tumors 
(Thorsson et al., 2018)(Figure 3B). The most immunologically active immune subtypes 
(e.g., C1, C2) tend to have the greatest spatial infiltration of lymphocytes. Within 
documented TCGA subtypes, which are typically characterized by specific molecular 
changes in tumor cells, strong differences are also seen (Figure S2A). EBV-positive gastric 
cancer is particularly rich in TILs, with an average of 25% of spatial regions infiltrated by 
TILs (Figure 3C). The lung squamous secretory subtype (Wilkerson et al., 2010) is also 
particularly rich in infiltrate (17%, Figure 3D) as is the mutation-rich POLE subtype of 
endometrial cancer. Among breast cancer tumors, the basal subtype has the greatest infiltrate 
(Figure 3E), consistent with what has been observed in other studies (Iglesia et al., 2014). 
Taken together, these data show that the nature of the infiltrate has strong ties to aspects of 
the tumor microenvironment and that the nature of the infiltrate may be reflective of 
particular molecular aberration states of tumor cells.
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The spatial fraction of TILs was compared with molecular estimates of TIL content from 
molecular genomics assays (Thorsson et al., 2018). The molecular estimate of TIL fraction 
is obtained by multiplying an estimate of the overall leukocyte fraction, based on DNA 
methylation arrays, with an estimate of the lymphocyte proportion within the immune 
compartment obtained by applying CIBERSORT (Newman et al., 2015) to RNA sequencing 
data. Good, albeit imperfect, agreement is seen between the imaging and molecular 
estimates (Figure 4A), with Spearman correlation values ranging from 0.20 to 0.45 for the 
most part accompanied by highly significant p values, and with UVM, the negative control, 
showing no correlation. The reasons for the differences between the molecular estimates and 
spatial TIL fraction include: (1) molecular data are extracted from a fresh frozen tissue 
section in proximity to the formalin-fixed paraffin-embedded (FFPE) sample used to 
generate the diagnostic H&E image, but the exact spatial relation is unknown; (2) the 
molecular estimate is proportional to the number of lymphocytes, whereas the spatial 
fraction of TILs is estimated by tissue area; (3) the spatial analysis and TIL fraction are an 
assessment of lymphocyte-infiltrated tissue that can also include non-tumor regions on the 
diagnostic slides; and (4) the molecular quantification is obtained from frozen sections that 
are highly enriched for tumor as a criterion for project inclusion. We further examined the 
outlier cases (see Figures 4B and 4C) having high levels of discordance between molecular 
and spatial image-derived TIL estimates for several tumor types, including BRCA, SKCM, 
LUAD, LUSC, STAD, and READ. We determined that spatial TILs in non-tumor regions 
appeared to play a major explanatory role (Figures S3B and S3C). Attempts to exclude such 
areas by manual negative masking and/or CNN-based automation for tumor recognition will 
be included in future efforts in order to reduce the discordance between the molecular 
estimates from samples that are highly enriched for tumor and the spatial TIL estimates 
derived from diagnostic H&E images.
Automated Assessment of Local Structures in the TIL Infiltrate and Association with 
Molecular and Clinical Readouts
Local Spatial Structure of the Immune Infiltrate—A unique feature of imaging data 
is the ability to go beyond total lymphocytic infiltrate load to the assessment of patterns of 
lymphocytic infiltration. To identify such patterns, we first used affinity propagation (Frey 
and Dueck, 2007) to find spatially connected and coherent regions (clusters) of TIL image 
patches (APCluster R package; Bodenhofer et al., 2011). Examples of H&E images, TIL 
maps, and clusters are shown in Figures 5A–5D for selected cases exemplifying sparse and 
dense lymphocyte infiltrates. For each slide, the resulting cluster pattern was characterized 
using measures for simple count and extent statistics but also by clustering indices, which 
assess more complex characteristics such as cluster shape. Summary measures include the 
number of clusters Ncluster, the mean number of TIL patches in the clusters NP, the mean of 
the within-cluster dispersion WCD, and the mean of cluster spatial extents CE (see Figure 
5E, Method Details, and Table S1). In terms of TIL patch distances to a given cluster center, 
the dispersion is related to their variance, while spatial extent is akin to the maximal 
distance. Ncluster ranged from 2 to 46 over the entire cohort (4,480 cases, excluding non-
tumor slides), with a median of 12, and the mean cluster membership was 293 TIL patches. 
We calculated the clustering indices of Ball and Hall (1965), Banfield and Raftery (1993), 
the C index, and the determinant ratio index, as implemented in the R package clusterCrit 
Saltz et al. Page 8
Cell Rep. Author manuscript; available in PMC 2018 May 10.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
(see Method Details and Table S1). The Ball-Hall index is the mean of the dispersion 
through all of the clusters, equivalent to the mean of the squared distances of the points of 
the cluster with respect to its center. In our data, the Ball-Hall index is correlated (ρSpearman 
= 0.95) with the mean cluster extent, CE. The Banfield-Raftery index is the weighted sum of 
the logarithms of the mean cluster dispersion, which in our data correlates with Ncluster 
(ρSpearman = 0.95). We found similarity among several of the various scores (Figure S4A), 
including overall trending of some clustering indices to simpler measures such as Ncluster 
and TIL fraction. The C index is derived from pairwise distances and does not scale with any 
of the simpler measures. Values of these scores for the cases depicted in Figures 5A–5D are 
shown in Figure 5E. Clustering indices vary widely over slides, as illustrated in Figure 6A 
for the Ball-Hall index. Tumors with relatively high values of this index, such as BRCA and 
PRAD, are not among those with highest overall infiltrate (Figure 3A). Since the Ball-Hall 
index scales with approximately cluster extent, this implies that, in some of these tumor 
types of moderate infiltrate mass, TIL clusters of relatively large spatial extent are formed. 
In summary, this implies that, in some tumor types, local clustering of TILs may be a more 
distinctive feature than overall TIL infiltrate, in comparison with other tumor types.
Correlates of Local TIL Spatial Structure with Survival—We examined the extent to 
which TIL fraction might impact overall survival and the extent to which spatial 
characteristics of the tumor microenvironment—beyond overall densities—may provide 
additional predictive power of outcome. We used Cox regression, accounting for age and 
gender as additional clinical covariates to perform survival analysis. In order to mitigate 
possible problems in interpretation due to the inherent correlation between some clustering 
indices and the TIL densities, we used linear regression to obtain adjusted cluster indices by 
computing residuals with respect to TIL density (see Method Details). p values were 
obtained for four adjusted indices and 13 tumor types, which were then adjusted for multiple 
testing using the Benjamini-Hochberg procedure. Five associations between cluster index 
and outcome were significant (at p < 0.05) and are shown in Figure 6B. Interestingly, the 
various indices were significant across different tumor types. Examples of Kaplan-Meier 
curves for median-split clustering indices are shown in Figures 6C (BRCA) and 6D 
(SKCM). In SKCM, increased Banfield Raftery-index (“cluster count”) associates with 
superior survival, while in BRCA increased Ball-Hall index (“cluster extent”) associates 
with inferior survival, both adjusted for overall TIL density. Of interest, checkpoint 
inhibition immunotherapy has been successfully applied to melanoma, while breast cancer 
tumors have generally been unresponsive to checkpoint blockade therapy. The association of 
structure with survival, as evidenced by less favorable survival in tumors with elevated 
adjusted Ball-Hall index (“cluster extent”) could be worthy of further investigation as a 
stratification factor for patient tumors in clinical studies of response.
Characterization of Overall TIL Map Structural Patterns and Association with Molecular 
Estimates
We undertook further characterization of TIL spatial structure, looking beyond local spatial 
structures toward a global structure classification that reflects standard descriptions in 
current use by practicing pathologists. We incorporated qualitative and semiquantitative 
descriptions and scoring of the TIL map structural patterns in the combined intratumoral and 
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peri-tumoral regions (collectively referred to as “tumor”) that are grossly defined by the 
corresponding H&E-stained whole-slide images.
As seen in the recommendations from of the International TILs Working Group (Salgado et 
al., 2015), International Immuno-oncology Biomarkers Working Group (Hendry et al., 
2017a, 2017b), and the prognostic descriptions used to characterize TILs in cutaneous 
melanoma (Crowson et al., 2006), pathologists classify patterns within the TIL maps in both 
the intratumoral and peritumoral regions. Correspondingly, patterns in the 5,202 TIL maps 
were visually assigned by a pathologist into one of five categories: “Brisk, diffuse” for 
diffusely infiltrative TILs scattered throughout at least 30% of the area of the tumor (1,856 
cases); “Brisk, band-like” for immune responses forming band-like boundaries bordering the 
tumor at its periphery (1,185); “Non-brisk, multi-focal” for loosely scattered TILs present in 
less than 30% but more than 5% of the area of the tumor (1,083); “Non-brisk, focal” for 
TILs scattered throughout less than 5% but greater than 1% of the area of the tumor (874); 
and finally “None” in 143 cases where few TILs were present involving 1% or less of the 
area of the tumor (see Method Details). TIL maps with corresponding H&E images with 
insufficient or no grossly identifiable tumor at low magnification were designated as 
indeterminate (61). The examples in Figures 5A–5D are categorized as follows: Figure 5A, 
TCGA-33-AASL Brisk, diffuse pattern in a case of squamous cell carcinoma of the lung 
showing a relatively strong immune infiltrate within the tumor; Figure 5B, TCGA-D3-A2JF 
Brisk, band-like pattern in a case of cutaneous melanoma showing immune infiltrates 
forming boundaries bordering the tumor at its periphery and < 30% TILs in the intratumoral 
component; Figure 5C, TCGA-E9-A22H Non-brisk, multi-focal pattern in a case of invasive 
ductal carcinoma of the breast showing a weak immune response with loosely scattered 
TILs; Figure 5D, TCGA-EW-A1OX Non-brisk, focal pattern in a case of invasive ductal 
carcinoma of the breast showing a very weak immune response in a focal area (categories 
also listed in final column of Figure 5E).
The TIL map global patterns are not distributed in an equal manner among TCGA tumor 
types. Figure 7A shows the ratio of observed counts over those expected randomly. BRCA is 
enriched in the “Non-brisk, focal” phenotype (374 observed; 166 expected; p value < 3 × 
10−16, Fisher’s exact test, Benjamini-Hochberg adjusted). PAAD is enriched in the “Non-
brisk, multi-focal” phenotype (70 observed; 36 expected; p = 8 × 10−8), as is PRAD (151; 
70; p < 3 × 10−16). The “Brisk, band-like” phenotype is most enriched in SKCM (134; 86; 3 
× 10−7) and very rare in PAAD (7; 37; 2 × 10−9) and PRAD, whereas “Brisk, diffuse” is 
more prevalent in STAD, READ, and CESC (p = 2 × 10−13, 4 × 10−6, and 3 × 10−10, 
respectively). Some TCGA subtypes also show enrichment in particular patterns (Figure 
S5A). For example, EBV-positive GI cancers are enriched in the “Brisk, diffuse” phenotype 
(14; 5; 6 × 10−3). Differences are also seen among immune subtypes (Figure S5B) defined in 
the TCGA pan-immune analysis (Thorsson et al., 2018), where the C4 subtype is enriched in 
the “Non-brisk, focal” (82; 44; 6 × 10−8). This is noteworthy, as subtype C4 is relatively 
richer in cells of the monocyte/macrophage lineage, which may play a role in sculpting the 
TME as evidenced in these patterns. Interestingly, the immune subtype C3, which tends to 
have good prognosis overall, has relatively few “Brisk band-like” structures (59; 162; < 3 × 
10−16), perhaps reflective of the more moderate and tempered immune response or 
productive infiltration of lymphocytes into tumor regions. C2, which has relatively poor 
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outcome, is somewhat richer in “Brisk” phenotypes, consistent with expectations that the 
relatively large degree of lymphocytic infiltrates are not adequately controlling tumor growth 
in this class of tumors. In summary, the global structural patterns show associations with 
distinct immune responses that can be either particular to subtypes, or shared across multiple 
tumor types, and may play a role in the determining the nature of the immune responses in 
the corresponding tumor microenvironments.
We also examined whether there was evidence of differences in the types of lymphocytes, 
such as signatures for CD4 T cells, CD8 T cells, B cells, and NK cells, represented in each 
phenotype. These cells cannot be distinguished by the H&E image analysis, but estimates of 
their proportions are available through analysis of the molecular data (Thorsson et al., 2018 
and Method Details). Averaging these values within structural patterns, we see emerging 
relationships (Figures 7B and S5C), where “Brisk” phenotypes have a higher proportion of 
CD8 T cells than those seen in the “Non-Brisk” phenotypes (mean 13.2% versus 10.7%, p 
value < 2.2 × 10−16, Mann–Whitney–Wilcoxon test). Correspondingly, “Non-Brisk” 
phenotypes tend to have a slightly greater proportion of CD4 T cells (p = 0.03). Thus, by 
combining molecular estimates of cell proportion with structural analysis of imagining data, 
we see evidence that particular T cell subsets may play distinct roles in the formation of 
global structural patterns.
DISCUSSION
The scanned archival H&E archives of the TCGA are a rich but quite underutilized resource 
within this project. In effect, it is a largely ignored source of data that has only been 
manually and sporadically mined and awaits more systematic characterization using the 
variety of analytic tools and analyses currently available. These images have generally been 
used solely to ensure the correct diagnosis, and panels of expert pathologists also used the 
images to glean other variables such as mitotic activity, tumor grade, and histologic subtypes 
for some of the TCGA marker papers. The recently published sarcoma TCGA marker paper 
utilized automated feature extraction of nuclear properties for correlation with copy number 
load and genomic doubling (Cancer Genome Atlas Research Network, 2017). The cutaneous 
melanoma TCGA marker paper used a visual inspection of expert pathologists to assess the 
degree and pattern of lymphocytes in the frozen section images of the tissue going to the 
molecular platforms to correlate with other genomic and proteomic assessments of 
lymphocytic infiltrate and also directly with clinical outcome (Cancer Genome Atlas 
Network, 2015). This was a manual process done by expert pathologists, and there was no 
attempt at automation. The efforts presented in this present work represent an initial attempt 
to systematically employ automated image processing to assess lymphocytic infiltrates 
across multiple TCGA tumor types for correlation with genomic and epigenomic 
assessments of lymphocytic infiltrates, as well as clinical outcome. Our sincere hope is that 
this early attempt to exploit this remarkable TCGA resource of associated scanned histologic 
images will spur others to similar approaches.
We report a scalable and cost-effective methodology for computational staining to extract 
and characterize lymphocytes and lymphocytic infiltrates in intratumoral, peri-tumoral, and 
adjacent stromal regions. In comparing TIL fraction identified via molecular methods to TIL 
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maps derived from digital image analyses of H&E images, we found good but certainly not 
perfect agreement. Several factors may be contributing. First, perfect agreement is not 
expected, since the estimates being compared are not of the same quantity or source. Indeed, 
the molecular estimates are analogous to cell count ratios, and the image fractions 
correspond to the proportion of spatial areas that contain TILs. Second, the exact spatial 
relation between the sample from which the molecular data is extracted (between the so-
called frozen tissue top-section and bottom-section) and the diagnostic images from the 
FFPE examples used to generate the diagnostic H&E slides is not known. The TIL maps are 
derived from high-quality scanned diagnostic FFPE H&E slides from tissue samples in an 
adjacent or possibly a more distant portion of the tumor relative to where the top and bottom 
frozen sections are sampled. Unfortunately, the frozen section images are not of a quality 
that permits robust features extraction. Even though some degree of correlation is certainly 
expected since TIL status is often a property of the tumor as a whole, upon further 
evaluation, we observed regional differences in a subset of samples within the overall 
assessment. These differences are largely explained by the effect of spatial TILs in non-
tumor regions in the diagnostic H&E images, which appeared quite different than the spatial 
TILs in the frozen section samples used for molecular TIL estimates.
Integrated analysis of TIL maps and molecular data reveals patterns and associations that 
can improve our understanding of the tumor microenvironment, and we illustrate some 
emerging relationships in this work. Both local patterns and overall structural patterns are 
differentially represented among tumor types, immune subtypes, and tumor molecular 
subtypes, the latter of which are typically driven by particular molecular alterations in the 
tumor cell compartment. This implies that the nature of spatial lymphocytic infiltrate state 
may be reflective of particular aberration states of tumor cells. In some tumor types (such as 
PAAD and PRAD), local clustering of TILs may be a more distinctive feature than overall 
TIL infiltrate, as compared with other tumor types. Structural patterns are further seen to be 
associated with survival, implying that the nature and effectiveness of immune response is 
encoded in patterns that may be assessable at the time of tumor diagnosis. For example, in 
breast cancer, less favorable survival in tumors with elevated adjusted Ball-Hall index 
(“cluster extent”) might be worth further investigation in terms of stratification of patient 
tumors in clinical studies of response. Overall structural patterns show associations with 
immune responses that are shared across multiple tumor types and may thus play a role in 
the determining the nature of those responses. For example, tumors with C2 immune 
subtypes, which tend to have relatively poor outcome, are somewhat richer in “Brisk” 
phenotypes, consistent with expectations that the relatively large degree of lymphocytic 
infiltrates are not adequately controlling tumor growth in these tissues. The immune subtype 
C3, which tends to have good prognosis overall, has fewer “Brisk band-like” structures, 
perhaps reflective of the more moderate and tempered immune response, or productive 
infiltration of lymphocytes into tumor regions. In contrast, tumors with the C4 immune 
subtype, which tends to be rich in cells of the monocyte/macrophage lineage, tend to have 
more “Non-brisk, focal” structures that may play a role in sculpting the TME as evidenced 
in these patterns. Finally, these patterns are enriched in particular T cell subpopulations as 
derived from molecular measures. For example, “Brisk” phenotypes have a higher 
proportion of CD8 T cells than those seen in the “Non-Brisk” phenotypes.
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A number of factors can contribute to cancer patient outcome. In our analyses, we attempted 
to control for age and sex, but other factors such as tumor grade could affect the presence or 
function of tumor-infiltrating lymphocytes. Grade is more challenging to control for across 
tumor types, as some are not graded such as melanoma while others such as breast and 
prostate cancer have very different grading systems that are challenging to compare 
rigorously. We readily accept that tumor grade and potentially other factors could influence 
lymphocytic infiltrates in both degree and pattern.
These analyses and early results demonstrate the vast potential of combining analysis of 
spatial structure with advanced genomics and molecular assessment, as the TIL information 
is being provided in the context of tumor molecular data wide in detail and in scope. The 
TCGA molecular datasets and the characterizations performed on them through the work of 
the PanCancer Atlas consortium, including those on the tumor-immune interface and the 
tumor microenvironment, provide an extraordinarily rich source of correlative molecular 
information for our discovered TIL patterns.
H&E imaging is performed routinely in labs throughout the world as a component of tumor 
diagnostics. Methods for extracting information on TILs from H&E scanned images are 
potentially of enormous research validity and possible clinical applicability—hundreds of 
thousands of whole-slide images exist in public repositories, in hospital system databases, 
and many more will be generated for years to come. In a clinical setting, rapid and 
automated identification of the degree and nature of TIL infiltrate might be instrumental in 
determining whether options for immunotherapy should be explored or whether more 
detailed and costly immune diagnostics should be introduced. Indeed, our approach might 
also complement immunophenotyping data, and the patterns of immune infiltration assessed 
by pathologists are already widely employed in the standard clinical reports of primary 
melanomas as a prognostic factor. Applying methods like those we present here could also 
allow for very incisive research at very reasonable price points and levels of convenience. 
These kinds of analyses can only improve with more detailed molecular-marker-based 
assays such as immunohistochemistry, which are not currently applied in most standard 
clinical settings due to lack of clinical necessity. Since the TCGA cohorts often predate the 
broad clinical application of effective immunotherapy such as checkpoint inhibitors and 
contain little data regarding outcomes with such therapy, association of our TIL estimates 
and derived infiltration patterns await more appropriate datasets to test associations.
We believe our CNN-derived TIL mapping provides a reproducible and robust tool for the 
assessment of these lymphocytic infiltrates. The ability to assess this tumor feature is rapidly 
becoming vital to both clinical diagnosis and translational research for onco-immunologic 
cancer care. These results show that this approach correlates with molecular assessments of 
TILs generated by the molecular platforms of the TCGA and can also correlates with 
clinical outcome for certain tumor types. Importantly, this study shows the value of feature 
extraction from the information-rich resource of the scanned H&E image archive of the 
TCGA. This resource has not been exploited to the degree of the other TCGA molecular and 
clinical outcome resource and clearly not to the degree it can support. This present study 
demonstrates value that can be added by careful examination of this rich resource, and it is 
our sincere hope that others will soon explore the many facets of these imaging data.
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DeconvNet Noh et al., 2015 https://github.com/HyeonwooNoh/DeconvNet
CIBERSORT Newman et al., 
2015
https://cibersort.stanford.edu/
APCluster Bodenhofer et 
al., 2011
https://cran.r-project.org/web/packages/apcluster/index.html
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Comprehensive 
R Archive 
Network 
(CRAN)
https://cran.r-project.org/web/packages/clusterCrit/
polycor Drasgow, 2014 https://cran.r-project.org/package=polycor
Other
Data (images, clinical and 
molecular) used in this study
National Cancer 
Institute 
Genomics Data 
Commons
https://gdc.cancer.gov/about-data/publications/tilmap
CONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests for resources should be directed to and will be fulfilled by 
the Lead Contact, Vésteinn Thorsson (Vesteinn.Thorsson@systemsbiology.org).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Human Subjects—A total of 4612 participants were included in this study. This study 
contained both males and females, with inclusions of genders dependent on tumor types. 
There were 2655 females and 1957 males. TCGA’s goal was to characterize adult human 
tumors; therefore, the vast majority of participants were over the age of 18. However, one 
participant under the age of 18 had tissue submitted prior to clinical data. Age was missing 
for 40 participants. The range of ages was 15–90 (maximum set to 90 for protection of 
human subjects) with a median age of diagnosis of 63 years of age. Institutional review 
boards at each tissue source site reviewed protocols and consent documentation and 
approved submission of cases to TCGA. Detailed clinical, pathologic and molecular 
characterization of these participants, as well as inclusion criteria and quality control 
procedures have been previously published for each of the individual TGCA cancer types.
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Sample Inclusion Criteria—Surgical resection of biopsy bio-specimens were collected 
from patients that had not received prior treatment for their disease (ablation, chemotherapy, 
or radiotherapy). Institutional review boards at each tissue source site reviewed protocols 
and consent documentation and approved submission of cases to TCGA. Cases were staged 
according to the American Joint Committee on Cancer (AJCC). Each frozen primary tumor 
specimen had a companion normal tissue specimen (blood or blood components, including 
DNA extracted at the tissue source site). Adjacent tissue was submitted for some cases. 
Specimens were shipped overnight using a cryoport that maintained an average temperature 
of less than −180°C.
Pathology quality control was performed on each tumor and normal tissue (if available) 
specimen from either a frozen section slide prepared by the BCR or from a frozen section 
slide prepared by the Tissue Source Site (TSS). Hematoxylin and eosin (H&E) stained 
sections from each sample were subjected to independent pathology review to confirm that 
the tumor specimen was histologically consistent with the allowable hepatocellular 
carcinomas and the adjacent tissue specimen contained no tumor cells. Adjacent tissue with 
cirrhotic changes was not acceptable as a germline control, but was characterized if 
accompanied by DNA from a patient-matched blood specimen. The percent tumor nuclei, 
percent necrosis, and other pathology annotations were also assessed. Tumor samples with ≥ 
60% tumor nuclei and ≤ 20% or less necrosis were submitted for nucleic acid extraction.
METHOD DETAILS
Image and Molecular Data Acquisition—Whole-slide tissue images were obtained 
from the public TCGA Data Portal (images are currently available from the Genomic Data 
Commons (GDC) Legacy Archive, following the deprecation of the TCGA Data Portal). Our 
study uses the diagnostic images, with some images from frozen tissue specimens used in 
the analysis of discrepancies with molecular estimates. The images were downloaded in the 
native image format, Aperio SVS files, in which they had been scanned. An SVS file stores 
an image in multiple resolutions, including the highest resolution the image data was 
captured; for example in an image that is acquired at a 40x magnification, each pixel is 
~0.25 × 0.25 microns. An open source library called OpenSlide (http://openslide.org/
formats/aperio/) was used to extract the highest resolution image data for our study. 5455 
diagnostic slides were analyzed the 13 TCGA tumor types in the study.
Clinical and molecular data were obtained from processed and quality controlled files of the 
PanCancer Atlas consortium, available at (https://gdc.cancer.gov/about-data/publications/
pancanatlas).
Convolutional Neural Networks for TIL Maps—Our overall methodology consists of 
two CNNs (a lymphocyte-infiltrated classification CNN (lymphocyte CNN) and a necrosis 
segmentation CNN), as well as mechanisms for capturing and incorporating feedback from 
pathologists, to evaluate and refine a generated Tumor-Infiltrating Lymphocyte (TIL) Map.
As is presented in the Results section, the lymphocyte CNN classifies image patches. Only 
foreground patches are processed and classified. To determine if a patch is a foreground 
patch, our analysis pipeline checks if the patch has enough tissue using the variance in Red, 
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Green and Blue channels of the patch. A patch is labeled background and discarded if 
(σ(Red) + σ(Green) + σ(Blue))/3 < 18. The values of the Red, Green, and Blue channels 
range from 0 to 255. The threshold value of 18 was selected by adjusting it across several 
slides. We compute percent TIL values using only the foreground patches (i.e., patches with 
tissue). Note the set of patches with tissue includes TIL patches.
TIL% = (Number o f TIL Patches)/(Number o f Patches with Tissue)
The lymphocyte CNN is a semi-supervised CNN, initialized by an unupervised 
Convolutional Autoencoder (CAE). The CNN and the CAE are designed to have relatively 
high resolution input such that one can recognize individual lymphocytes. We have chosen 
to apply unsupervised CAE pre-training because many studies have shown that it boosts the 
performance of the CNN, please refer to our technical report (Hou et al., 2017). Using the 
lung adenocarcinoma (LUAD) patches, we empirically showed that the CNN without pre-
training achieved significantly lower area under the curve (AUC). The CAE encodes 
(compresses) an input image patch of 50 × 50 μm2 (100 × 100 square pixels, corresponding 
to 20x magnification) into several vectors of length 100, and then reconstruct the input 
image patch using these encoding vectors. We train the CAE in an unsupervised fashion, to 
minimize the pixel-wise image patch reconstruction error, with limited number of encoding 
vectors. By doing this, the CAE implicitly learns to encode the position, appearance and 
morphology etc. of nuclei, in the encoding vectors. Our guideline of designing the 
architecture of the CAE is that, each encoding vector, in the ideal case, should be capable of 
encoding one and only one nucleus. As a result, the CAE has 13 encoding layers and 3 
pooling layers. The lymphocyte CNN is built based on the trained CAE: we discard the 
decoding (reconstruction) part of the CAE, and added several more layers on the encoding 
vectors. Therefore, our lymphocyte CNN is a 18-layer network with 14 convolutional layers, 
3 pooling layers, and 1 fully connected layer (Zhao et al., 2017).
We use two different CNNs for classification of necrosis regions and TILs, because our 
experiments showed necrosis regions and lymphocytes are best recognized and classified at 
different image scales. The necrosis CNN model performs best with larger input tissue 
regions, whereas the lymphocyte CNN model achieves the best results with local, high-
resolution image patches. The necrosis segmentation CNN is used to eliminate false 
positives from the lymphocyte CNN in necrotic regions. In these regions, nuclei may have 
characteristics similar to those in lymphocyte infiltrated regions. Because recognizing a 
region of 50 × 50 μm2 need contextual information in a larger region, we model this as a 
segmentation problem with larger input patches at a relatively lower resolution: 500 × 500 
μm2 patches are extracted from the image and downsampled 3 times. The resulting patch is 
333 × 333 pixels at 20x magnification. The necrosis segmentation CNN outputs pixel-wise 
segmentation results. We use DeconvNet (Noh et al., 2015) for this task because it is 
designed to predict pixel-wise class labels and handle structures and objects at multiple 
scales (which is more suitable for segmentation than patch-level classification) and it has 
been shown to achieve high prediction accuracy with several benchmark image datasets. We 
train DeconvNet to classify each pixel as inside or outside a necrosis region. The output of 
the necrosis segmentation CNN is resized to match the output resolution of the lymphocyte 
Saltz et al. Page 16
Cell Rep. Author manuscript; available in PMC 2018 May 10.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
CNN. If over half of a 50x50 patch intersects with a necrotic region, the patch is classified as 
non-lymphocyte-infiltrated.
Convolutional Autoencoder Details—The Convolutional Autoencoder (CAE) contains 
one branch with a small number of low resolution, dense features maps, and a second branch 
with high resolution, but sparse feature maps The high resolution sparse feature maps are 
designed to capture foreground objects (e.g., cancer cell nuclei and lymphocytes) - these 
objects are sparsely distributed in the tissue and contain substantial high spatial frequency 
color and texture variability. The network learns foreground feature maps in a “crosswise 
sparse” manner: neurons across all feature maps are not activated (output zero) in most 
feature map locations. Only neurons in a few feature map locations can be activated. Since 
the non-activated neurons have no influence in the later decoding layers, the image 
foreground is reconstructed using only the non-zero responses in the foreground encoding 
feature maps. The low resolution dense feature maps are designed to encode background 
color and texture of the background. We first model the background (tissue, cytoplasm etc.) 
and then extract the foreground that contains nuclei.
The supervised CNN takes the unsupervised encoded features from the unsupervised CAE 
for classification. We initialize the parameters in these layers to be the same as the 
parameters in the CAE. We attach four 1x1 convolutional layers after the foreground 
encoding layer and two 3x3 convolutional layers after the background encoding layer. Each 
added layer has 320 convolutional filters. We then apply global average pooling on the two 
branches. The pooled features are then concatenated together, followed by a final 
classification layer with sigmoid activation function (Hou et al., 2017).
CNN Training and Testing Details—We train our CAE on the unlabeled dataset, 
minimizing the pixel-wise root mean squared error between the input images and the 
reconstructed images. No regularization loss is deployed. We use stochastic gradient descent 
with batch size 32, learning rate 0.03 and momentum 0.9, and train the network until 
convergence (6 epochs).
For the lymphocyte CNN (constructed from the CAE) training, we use stochastic gradient 
descent with batch size 100, learning rate 0.001, and momentum 0.985. We train the CNN 
until convergence (64 epochs) and divide the learning rate by 10 at the 20th, 32th, and 52th 
epoch. We use sigmoid as the nonlinearity function in the last layer and log-likelihood as the 
loss function. No regularization loss is deployed. We apply three types of data augmentation. 
First, the input images are randomly cropped from a larger image. Second, the colors of the 
input images are randomly perturbed. Third, we randomly rotate and mirror the input 
images. We trained the CAE and CNN on a single Tesla K40 GPU. During testing phase, we 
augmented the test patch 24 times and averaged the prediction results. The CAE and CNN 
used the Theano library (http://deeplearning.net/software/theano/).
CNN-VGG Comparison Experiment Details—We fine-tuned the VGG 16-layer 
network which was pre-trained on ImageNet. Fine-tuning the VGG16 network has been 
shown to be robust for pathology image classification (Xu et.al. 2015; Hou et al., 2016b). 
We used stochastic gradient descent with batch size 32, learning rate 0.0001, and momentum 
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0.985. We trained the lymphocyte CNN until convergence (32 epochs). We used the same 
loss function and data augmentation method used for the proposed CNN. To match the input 
size of the VGG16 network, we re-sized the input patches from 100 × 100 pixels to 224 × 
224 pixels. Same as the proposed CNN, during testing phase, we augment the test patch 24 
times and average the prediction results.
Iterative Model Training and Data Labeling—We have implemented an iterative 
workflow as depicted in Figure S1 in order to train the CNN models. First, an unsupervised 
image analysis of WSIs is executed to initialize a CNN model. This model is refined in an 
iterative process in which CNN predictions are reviewed, corrected and refined by expert 
pathologists and the CNN model is re-trained with the updated data in order to improve its 
classification performance. After a training phase, the CNN model is applied to patches in 
the test set. For each test patch, the lymphocyte CNN produces a probability of the patch 
being a lymphocyte-infiltrated patch. The label of the patch is decided by simple 
thresholding; if the probability value is above a predefined threshold, the patch is classified 
as lymphocyte-infiltrated.
Training a fully supervised CNN requires a large number of training instances with ground 
truth labels. Masci et al. (Masci et al., 2011) have shown that utilizing unlabeled instances 
can boost the performance of a CNN. Drawing from those findings, we first trained an 
unsupervised Convolutional Auto-Encoder (CAE) to learn the representation of nuclei and 
lymphocytes in histopathology images and initialize the lymphocyte CNN (Zhao et al., 
2017). In this way, the initial lymphocyte CNN model captures the appearance of 
histopathology images without supervised training. We initialized the weights of the necrosis 
segmentation CNN randomly following the DeconvNet approach. We then trained the CNNs 
with labeled images. The training phases of the CNNs involve a cross-validation step to 
assess prediction performance and avoid overfitting (Hou et al., 2017).
Review and Refinement of CNN Predictions—We developed a web application, 
called the TIL-Map editor, to support the review and refinement by the pathologists of the 
tumor-infiltrating lymphocyte patch predictions and the segmentation of necrotic regions. 
The TIL-Map editor extends caMicroscope (Sharma et al., 2014) interface to enable the 
visualization of patch-level classification labels as a heatmap overlay on a WSI. It is 
distributed as part of a suite of tools called QuIP - Quantitative Imaging for Pathology (Saltz 
et al., 2017). QuIP is an open-source software system which consists of a suite of integrated 
data services and web-based user applications designed for the management and analysis of 
whole-slide tissue images and indexing and exploration of image features. When using the 
TIL-Map editor, a user can interactively visualize, pan, and zoom-in/out of the whole-slide 
tissue image and interactively pan and zoom around the image, in a manner similar to 
various online mapping systems. It display the TIL-Maps, as polygonal overlays that appear 
over the H&E image. The intermediate and final TIL Maps are stored in the QuIP 
FeatureDB, which manages and indexes both the image metadata and the TIL classification 
results. Figure 2B shows an example heatmap along with the TIL-Map editor.
Each patch in a WSI is represented as a rectangle and associated with a classification label 
and the probability value computed by the CNN. This information is stored as a data element 
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(document) in FeatureDB and indexed to speed up queries by the TIL-Map editor to retrieve 
and display subsets of patches. After classification results for a set of WSIs have been 
loaded to the database, a pathologist can use a web browser to view and update the 
classification results. The pathologist would use the TIL-Map editor to examine an image, 
query FeatureDB to retrieve patches visible within the view point and zoom level and 
display them as a two-color heatmap. The pathologist can edit the heatmap using the 
“Lymphocyte Sensitivity,” “Necrosis Specificity,” “Smoothness” sliders in a panel. These 
slides allow the pathologist to change the threshold value which determines if a patch should 
be classified as lymphocyte-infiltrated or not. For finer-grain editing of individual patches or 
sets of patches, the pathologist can use the “Markup Edit” function to markup specific 
patches and label them as lymphocyte-infiltrated or not-lymphocyte-infiltrated. The 
pathologist can then save the updated patch labels to the database. The updated patch labels 
are used to retrain the CNN. Changes to the heatmap are only visible to the user him/herself: 
multiple users can work independently selecting lymphocyte sensitivity and making finer-
grain editing in the same slide without knowing each other’s editing choices.
In this work, a team of three pathologists from Stony Brook Medicine and MD Anderson 
Cancer Center reviewed and refined 10 to 20 WSIs in each cancer type using the TIL-Map 
editor. Each image was assigned to two pathologists. Each pathologist separately adjusted 
the “Lymphocyte Sensitivity,” “Necrosis Specificity,” “Smoothness” thresholds and 
manually edited regions in the images using the “Markup Edit” tool in order to generate an 
accurate patch-level classification in the entire image. Depending on the pathologists 
consensus, if retraining was needed, the pathologists collaboratively generated a consensus 
lymphocyte heatmap for each image. Data from these consensus heatmaps was input back to 
the lymphocyte CNN in a training step to further improve its performance.
Determining Lymphocyte Selection Thresholds—The trained lymphocyte and 
necrosis CNNs was applied to 5455 diagnostic slides available for the 13 TCGA tumor types 
in the study. We then determined selection thresholds based on overall probability estimates 
for each slide to correct for possible slide-specific bias, in which the CNN was seen to 
systematically over or under predicts lymphocytes depending on the overall characteristics 
of the whole slide. The process of determining the lymphocyte selection thresholds is shown 
in Figure S1. The first step is to classify each slide into categories that reflect whether there 
is systematic over or under prediction of lymphocytes. To do this. for each slide, ten patches 
were sampled from 10 ranges of the lymphocyte CNN’s scores (0.10–0.20, 0.20–0.25, 0.25–
0.30, 0.30–0.40, 0.40–0.50, 0.60–0.70, 0.70–0.80, 0.80–0.90, 0.90–1.00). Three pathologists 
labeled them as lymphocyte infiltrated or not. Based on the number of labeled lymphocyte/
non-lymphocyte patches, each slide was categorized into 1 of 7 groups: Groups A-G, based 
corresponding to 0,1,2,3–7,8,9, and 10 positive patches respectively. The second step is to 
select a threshold in each group. In each group, we randomly selected 8 slides and manually 
adjusted thresholds for each of them using our visual TIL-Map editor. The threshold of all 
slides in one group was set to be the average threshold selected for the eight slides sampled 
in that group. Note that if we categorize the slides into more number of groups, then we have 
to manually select thresholds for more slides, since per group, a meaningful averaged 
threshold requires a minimum number of selected thresholds. On the other hand, if we 
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categorize the slides into fewer groups, the intra-group variance of possible slide-specific 
biases might be too large. Therefore, we select seven as the number of groups, striking a 
balance between efficiency and effectiveness.
Subsequent to processing as described above, incomplete TIL maps or those with failed 
predictions were removed, and for LUAD additional manual review was performed to 
remove TIL maps derived from poor slides, such as those that were out-of-focus or only 
partially visible. This resulted in 5202 TIL maps (see Figure S1C, Table S2) for further 
analysis and distribution. For a number of TCGA cases, multiple diagnostics slides are 
available, distinguished by TCGA slide ID barcode suffixes DX1, DX2, …, DX13. All cases 
have a DX1 diagnostic slide; hence these slides and corresponding TIL maps were used in 
subsequent correlative analyses. The 5202 slide-derived TIL maps correspond to 4759 
TCGA participants and slide IDs with suffix DX1.
Molecular Data Estimates of Immune Response—We used estimates of tumor and 
immune characteristics derived and made available in (Thorsson et al., 2018). The estimate 
of TIL fraction by genomics measurements is obtained as described therein, by multiplying 
overall leukocyte fraction derived from DNA methylation with an aggregated proportion of 
immune-cell fractions within the immune compartment estimated using CIBERSORT 
(Newman et al., 2015). The lymphocyte fraction is an aggregation of CIBERSORT estimates 
of naive and memory B cells, naive, resting and activated memory CD4 T cells, follicular 
helper T cells, T regulatory cells, gamma-delta T cells, CD8 T cells, activated and resting 
NK cells and plasma cells. To compare with these data with TIL estimates from images, 
participant and slide barcodes were restricted to those satisfying the inclusion criteria of the 
TCGA PanCancer Atlas and Immune Response Working Group. Of the 4705 cases with 
characterized TIL map clusters and patterns (see below), 4612 were thus available for 
molecular data integration and comparison (Table S1, see also Figure S1C, Table S2).
Local Spatial Structure of Immune Infiltrate—We used the APCluster R package 
(Bodenhofer et al., 2011) to apply the affinity propagation algorithm to obtain local TIL 
cluster patterns. The affinity propagation approach (Frey and Dueck, 2007) simultaneously 
considers all data points as potential exemplars (i.e., the centers of clusters) from among 
possible data points. Treating each data point as a node in a network, it recursively transmits 
real-valued messages along edges of the network until it finds a good set of exemplars and 
corresponding clusters. We define the similarities between data points (TIL patches) as the 
negative square Euclidean distance between them. Aside from the similarity matrix itself, 
the most important input parameter is the so-called “input preference” which can be 
interpreted as the tendency of a data sample to become an exemplar. The function apcluster 
in the package contains an argument q that allows setting the ‘input preference’ parameter to 
a certain quantile of the input similarities: resulting in the median for q = 0.5 and in the 
minimum for q = 0. To select this parameter, we generated synthetic data points in a plane 
comprising two distinct Gaussian clouds of points. Using the synthetic data, we observed 
that q = 0 was best able to cluster these points into two clusters, and used this value for 
identifying TIL clusters. Of the 5202 TIL maps, 5144 clustering results were generated (see 
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Figure S1C, Table S2), with the remainder failing to complete clustering runs in time or 
failing due to memory errors, mostly in slides with numerous TILs.
Cluster characterization was made using simple measures of counts and membership and 
cluster indices from the R package clusterCrit by Bernard Desgraupes. The Ball-Hall, 
Banfield-Raftery, C Index, and Determinant Ration indices are detailed in the package 
documentation.
Variable Definition or Reference
Number of TIL Patches TIL patch count
TIL fraction (TIL patch count)/(Total number of available patches on tissue slice)
Number of TIL Clusters Number of clusters, from affinity propagation clustering
Cluster Size Mean Mean of the cluster membership counts
Cluster Size Standard Deviation Standard deviation of the cluster membership counts
Within-Cluster Dispersion Mean Mean of the values of WGSSk, the within-cluster dispersion (see 
below)
Within-Cluster Dispersion Standard Deviation Standard deviation of the values of WGSSk
Cluster Extent Mean Mean of the maximum distances to clusters exemplars. The cluster 
examplar is the most representative TIL patch for the cluster, as 
defined in the affinity propagation method
Cluster Extent Standard Deviation Standard deviation of the maximum distances to exemplars
Ball Hall Index Ball and Hall (1965). Available at: http://www.dtic.mil/docs/citations/
AD0699616
Banfield Raftery Index Banfield and Raftery (1993)
C Index Hubert and Schultz (1976)
Determinant Ratio Index Scott and Symons (1971)
Ball Hall Index - TIL count adjusted ‘Adjusted’ refers to the residual of the corresponding index after 
regression against %TIL density
Banfield Raftery Index - TIL count adjusted ‘Adjusted’ refers to the residual of the corresponding index after 
regression against %TIL density
C Index - TIL count adjusted ‘Adjusted’ refers to the residual of the corresponding index after 
regression against %TIL density
Determinant Ratio Index - TIL count adjusted ‘Adjusted’ refers to the residual of the corresponding index after 
regression against %TIL density
In the above, WGSSk is a within-cluster dispersion which is the sum of the squared distances 
between the observations and the barycenter of the cluster (see https://CRAN.R-project.org/
package=clusterCrit) for details. To compute the adjusted indices, linear regression was used 
to model the relationship between the clustering index and the %TIL density. The regression 
residual was used as the adjusted index. Cluster characteristic were generated for all 5144 
slides with cluster results (4705 with DX1 suffix)(see Figure S1C, Table S2) and adjusted 
indices for 4509 cases.
Assessment of TIL Map Structural Patterns—In order to perform a comprehensive 
assessment of the TIL map structural patterns, the collection of 5202 H&E images (see 
above, 4759 with DX1 suffix) and the corresponding TIL maps were visually inspected to 
ensure that each H&E image had a correctly matched TIL map, after which, a subset of 500 
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H&E images and corresponding TIL maps were closely inspected at higher power 
magnification (100x to 200x) in 30–50 fields to ensure that the lymphocyte-detection 
algorithm was performing as intended and not mistakenly identifying tumor cells as 
lymphocytes across the various tumor types as a quality-control measure. We further 
employed H&E images and corresponding TIL maps from cases of uveal melanoma as 
negative controls because melanoma tumor cells and melanotic pigment can be a difficult 
challenge for the lymphocyte-detection algorithm.
After the negative controls were verified and quality measures were satisfactorily addressed, 
TIL maps (total N = 4455) were assessed in a two part fashion by a qualitative description 
and a semiquantitative score based on visual inspection with respect to the tumor region 
only, which is determined by histopathologic evaluation at low-power magnification (40x) of 
the corresponding H&E diagnostic whole-slide image. The tumor region represents the 
combined intra-tumoral and peri-tumoral regions and excludes the adjacent non-tumor 
regions.
The qualitative description characterizes the nature of the immune infiltrate with respect to 
the gross spatial distribution of the TILs in only the tumor region with terms like “Focal” 
(localized), “Multi-focal” (loosely scattered), “Diffuse” (spread out over a large area), and 
“Band-like” (well-defined boundaries bordering the tumor at its periphery). The 
semiquantitative scoring evaluates the relative strength of the immune response terms like 
“None,” “Non-brisk” (minimal to mild partial immune response), and “Brisk” (moderate to 
strong immune response).
Taken together, “Non-brisk, focal” is indicative of a “very weak” but minimally present 
immune response with a low density of TILs in a localized area of the tumor, whereas “Non-
brisk, multi-focal” is indicative of a weak partial immune response with loosely scattered 
TILs in a few areas of the tumor. However, “Brisk, diffuse” represents a moderate to strong 
immune response with a relatively dense and spread out pattern of TILs across > 30% of the 
tumor even if there are band-like boundaries bordering the tumor at its periphery. The 
“Brisk, band-like” description was reserved for cases where the TIL map patterns showed 
relatively organized structures that appear as boundaries bordering the tumor at its periphery 
and < 30% TILs in the intra-tumoral component. “None” was selected in cases where few 
TILs were present in less than 1% of the area of the tumor and “Indeterminate” was used if 
there was insufficient or no grossly identifiable tumor in the H&E image at low-power with 
the corresponding TIL map regardless of pattern and semiquantitative distribution of TILs.
Summary Table of Criteria Used to Characterize TIL Map Structural Patterns
Category Immune Response Qualitative Pattern
Proportion of Tumor 
composed of 
Lymphocytes
Indeterminate Insufficient and/or no tumor 
in the H&E image at low-
power
Not applicable Not applicable
None No response No pattern <1% TILs
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Category Immune Response Qualitative Pattern
Proportion of Tumor 
composed of 
Lymphocytes
Non-brisk, focal Very Weak (minimal) Localized <5% TILs
Non-brisk, multi-focal Weak (mild) Loosely scattered foci >5%–30% TILs
Brisk, diffuse Moderate to Strong Diffuse and dense infiltrate >30% TILs in the intra-
tumoral component*
Brisk, band-like Not applicable Infiltrate bordering the tumor 
at its periphery
<30% TILs in the intra-
tumoral component*
*
If the TIL map patterns revealed both diffuse and band-like immune responses, the predominant pattern was characterized 
and the difference between “Brisk, diffuse” and “Brisk, band-like” was based on whether the relative distribution of TILs in 
the intra-tumoral component appeared to be greater than or less than 30%, respectively.
DATA AND SOFTWARE AVAILABILITY
The original H&E stained whole-slide images used in this work can be downloaded from the 
Genomic Data Commons. All TCGA molecular data can be obtained from the Genomic 
Data Commons, as well as derived data matrices of the PanCancer Atlas. Integration with 
immune signatures of the TCGA immune response working group is available through CRI 
iAtlas web resource. Links to these data resources can be found at the accompanying 
publication manuscript page (https://gdc.cancer.gov/about-data/publications/tilmap).
The analysis codes used in this work is version controlled has also been containerized and 
made available as a Docker image. The QuIP software for iterative refinement of CNN 
prediction results is also available. The training datasets for the CNN models and the TIL 
maps generated in this study are also available for download. These different software 
resources as well as the TIL maps are available on the Cancer Imaging Archive, at: https://
doi.org/10.7937/K9/TCIA.2018.Y75F9W1
QUANTIFICATION AND STATISTICAL ANALYSIS
The statistical details of all experiments are reported in the text, figure legends and figures, 
including statistical analysis performed, statistical significance and counts.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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TCGA Tumor Types Used in this Study
BLCA Bladder urothelial carcinoma
BRCA Breast invasive carcinoma
CESC Cervical squamous cell carcinoma and endocervical adenocarcinoma
COAD Colon adenocarcinoma
LUAD Lung adenocarcinoma
LUSC Lung squamous cell carcinoma
PAAD Pancreatic adenocarcinoma
PRAD Prostate adenocarcinoma
READ Rectum adenocarcinoma
SKCM Skin Cutaneous Melanoma
STAD Stomach adenocarcinoma
UCEC Uterine Corpus Endometrial Carcinoma
UVM Uveal Melanoma
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Highlights
• Deep learning based computational stain for staining tumorinfiltrating 
lymphocytes (TILs)
• TIL patterns generated from 4,759 TCGA subjects (5,202 H& slides), 13 
cancer types
• Computationally stained TILs correlate with pathologist eye and molecular 
estimates
• TIL patterns linked to tumor and immune molecular features, cancer type, and 
outcome
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Figure 1. Workflow for Training, Model Development, and Subsequent Generation of TIL Maps
Top: for training and developing CNN models, a pathologist reviews images and marks 
regions with lymphocytes and necrosis. These training data are then broken down into 
patches that are then fed into a training stage to train CNNs for lymphocyte and necrosis 
detection. A pathologist periodically reviews the results for accuracy and corrects the 
prediction. This results in a pair of Trained CNNs. Bottom: these trained CNNs are then 
used on the full set of 5,455 images from 13 cancer types to generate TIL maps. During TIL 
map generation, a probability map for TILs is generated from each image. These 
probabilities are then reviewed and lymphocyte selection thresholds are established using a 
selective sampling strategy (further information in Method Details). These thresholds are 
then used to obtain the final TIL maps. See also Figure S1 and Tables S1 and S2.
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Figure 2. Assessment of TIL Prediction
(A) Receiver Operating Characteristic depicting performance of CNN. Applied to TCGA 
lung adenocarcinoma patches. The current method is compared with a popular CNN called 
VGG16 (see main text description).
(B) Comparison of TIL scores of super-patches between pathologists and computational 
stain. x axis: median scores from three pathologists assessing 400 super-patches as having 
low, medium, or high lymphocyte infiltrate. y axis: scores from computational staining, on a 
scale from 0 to 64.
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Figure 3. TIL Fraction by Tumor Category
(A–E) Percent TIL fraction, the proportion of TIL-positive patches within a TIL map, is 
shown by various categorizations of TCGA tumor samples. Each plotted point represents a 
tumor sample for (A) 13 TCGA tumor types (4,612 cases), (B) six subtypes characterized by 
differences in the nature of the overall immune response (Thorsson et al., 2018) (C5 has very 
few samples here), (C) gastrointestinal adenocarcinoma subtypes, (D) lung squamous cell 
carcinoma subtypes, and (E) breast adenocarcinoma subtypes. See also Figure S2.
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Figure 4. Comparison of TIL Proportion from Imaging and Molecular Estimates
(A) Spearman correlation coefficients and p values for comparison of TIL fraction from 
spatial estimates of TIL maps and molecular estimates of TIL fraction from processing of 
cancer genomics data using deconvolution methods (see main text).
(B) Each point represents a breast adenocarcinoma tumor sample, with the value of TIL 
fraction from TIL maps (x axis) and from molecular estimates (y axis).
(C) As in B for 12 additional TCGA tumor types. See also Figure S3 and the companion 
manuscript (Thorsson et al., 2018).
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Figure 5. Examples of TIL Map Structural Patterns
(A–D) Four cases representing different degrees of lymphocyte infiltration. Each example is 
labeled by TCGA participant barcode and has the following three panels. Left: H&E 
diagnostic image at low magnification with tumor regions circled in yellow; middle: TIL 
map; red represents a positive TIL patch, blue represents a tissue region with no TIL patch, 
while black represents no tissue; right: diagrams of clusters of TIL patches derived from the 
affinity propagation clustering of the TIL patches. Line segments connect cluster members 
with a central representative for each cluster, and colors are arbitrarily assigned to aid visual 
separation of clusters.
(E) TIL map, cluster statistics, and global patterns for the four examples in A–D. Each 
column represents one way to characterize the TIL map, ranging from simple measures such 
as TIL count and density to more complex ones characterizing details of cluster properties 
and image patterns (see main text). See also Table S2.
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Figure 6. Associations of TIL Local Spatial Structure with Cancer Type and Survival
Associations are shown with cluster indices, which summarize properties of clusters derived 
from affinity propagation clusters of the TIL map—properties that provide details on local 
structure beyond simple densities.
(A) Ball-Hall cluster indices for all slide images considered in the study. The Ball-Hall index 
is a particular clustering index, summarizing the mean, through all the clusters, of their mean 
dispersion and is equivalent to the mean of the squared distances of the points of the cluster 
with respect to its center. In our data, the Ball-Hall index is correlated (ρSpearman = 0.95) 
with the mean cluster extent, CE.
(B) Table of significant associations between TIL fraction-adjusted cluster indices and 
overall survival based on Cox regression, accounting for age and gender as additional 
clinical covariates.
(C) Overall survival for median-stratified TIL fraction-adjusted Ball-Hall index in breast 
cancer. Significance test p value is shown in the lower left.
(D) Same as C but for adjusted Banfield-Raftery index in skin cutaneous melanoma. The 
Banfield-Raftery index is the weighted sum of the logarithms of the mean cluster dispersion 
and, in our data, often correlates with the number of clusters. See also Figure S4.
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Figure 7. Association of Spatial Structural Patterns with Tumor Type and Cell Fractions
(A) Each row corresponds to one of four spatial structure patterns, assigned in a manner 
consistent with the descriptions currently used to characterize the nature of the immune 
infiltrate in standard histopathological examinations, and each column is a TCGA tumor 
types. The values shown are the sample count for each tumor type and spatial structure 
pattern, divided by the counts expected by chance. The ratio of observed to expected co-
membership counts is shown on a color scale, where the largest ratios are in red, values near 
unity as yellow, and blue represents fewer than expected counts.
(B) Estimates of the proportion of CD4, CD8, NK cells, and B cells were segregated by 
spatial structure patterns and averaged. Bars show the proportion within each structural 
pattern. These proportions are estimated using molecular data of the TCGA. See also Figure 
S5.
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